$13.94
+0.29
(+2.12%)▲
Insights on Sabra Health Care Reit Inc
Revenue is up for the last 3 quarters, 161.16M → 164.38M (in $), with an average increase of 1.0% per quarter
Netprofit is up for the last 2 quarters, -15.10M → 17.15M (in $), with an average increase of 188.0% per quarter
In the last 1 year, Healthpeak Properties, Inc. has given 31.0% return, outperforming this stock by 6.1%
2.22%
Downside
Day's Volatility :3.09%
Upside
0.89%
33.79%
Downside
52 Weeks Volatility :38.1%
Upside
6.51%
Period | Sabra Health Care Reit Inc | Sector (Real Estate) | Index (Russel 2000) |
---|---|---|---|
3 Months | 1.94% | -5.4% | 0.0% |
6 Months | -1.73% | 10.8% | 0.0% |
1 Year | 24.89% | 0.0% | 2.2% |
3 Years | -25.45% | -13.9% | -23.0% |
Market Capitalization | 3.2B |
Book Value | $12.12 |
Dividend Share | 1.2 |
Dividend Yield | 8.71% |
Earnings Per Share (EPS) | 0.06 |
PE Ratio | 228.33 |
PEG Ratio | 3.15 |
Wall Street Target Price | 15.91 |
Profit Margin | 2.13% |
Operating Margin TTM | 32.93% |
Return On Assets TTM | 2.45% |
Return On Equity TTM | 0.47% |
Revenue TTM | 644.6M |
Revenue Per Share TTM | 2.79 |
Quarterly Revenue Growth YOY | 93.30000000000001% |
Gross Profit TTM | 372.8M |
EBITDA | 395.9M |
Diluted Eps TTM | 0.06 |
Quarterly Earnings Growth YOY | 0.29 |
EPS Estimate Current Year | 0.58 |
EPS Estimate Next Year | 0.64 |
EPS Estimate Current Quarter | 0.13 |
EPS Estimate Next Quarter | 0.14 |
What analysts predicted
Upside of 14.13%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 623.4M | ↑ 53.68% |
Net Income | 279.1M | ↑ 76.21% |
Net Profit Margin | 44.77% | ↑ 5.73% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 661.7M | ↑ 6.15% |
Net Income | 69.0M | ↓ 75.28% |
Net Profit Margin | 10.43% | ↓ 34.34% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 598.6M | ↓ 9.55% |
Net Income | 138.4M | ↑ 100.62% |
Net Profit Margin | 23.12% | ↑ 12.69% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 569.5M | ↓ 4.85% |
Net Income | -113.3M | ↓ 181.82% |
Net Profit Margin | -19.89% | ↓ 43.01% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 624.8M | ↑ 9.7% |
Net Income | -77.6M | ↓ 31.48% |
Net Profit Margin | -12.42% | ↑ 7.47% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 655.8M | ↑ 4.97% |
Net Income | 13.8M | ↓ 117.73% |
Net Profit Margin | 2.1% | ↑ 14.52% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 140.8M | ↓ 9.74% |
Net Income | -50.1M | ↓ 397.91% |
Net Profit Margin | -35.57% | ↓ 46.35% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 165.0M | ↑ 17.21% |
Net Income | -84.9M | ↑ 69.68% |
Net Profit Margin | -51.49% | ↓ 15.92% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 161.3M | ↓ 2.22% |
Net Income | -9.5M | ↓ 88.83% |
Net Profit Margin | -5.88% | ↑ 45.61% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 161.2M | ↓ 0.1% |
Net Income | 21.2M | ↓ 323.34% |
Net Profit Margin | 13.15% | ↑ 19.03% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 161.6M | ↑ 0.29% |
Net Income | -15.1M | ↓ 171.27% |
Net Profit Margin | -9.34% | ↓ 22.49% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 164.4M | ↑ 1.7% |
Net Income | 17.2M | ↓ 213.61% |
Net Profit Margin | 10.44% | ↑ 19.78% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 6.7B | ↓ 5.22% |
Total Liabilities | 3.4B | ↓ 5.13% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 6.1B | ↓ 8.94% |
Total Liabilities | 2.6B | ↓ 24.33% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 6.0B | ↓ 1.38% |
Total Liabilities | 2.6B | ↓ 0.17% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 6.0B | ↓ 0.32% |
Total Liabilities | 2.6B | ↑ 0.42% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 5.7B | ↓ 3.67% |
Total Liabilities | 2.7B | ↑ 4.02% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 5.4B | ↓ 6.29% |
Total Liabilities | 2.6B | ↓ 4.0% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 5.8B | ↓ 1.95% |
Total Liabilities | 2.6B | ↓ 0.28% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 5.7B | ↓ 1.66% |
Total Liabilities | 2.7B | ↑ 2.09% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 5.6B | ↓ 3.33% |
Total Liabilities | 2.6B | ↓ 4.13% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 5.5B | ↓ 0.58% |
Total Liabilities | 2.6B | ↑ 0.02% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 5.4B | ↓ 2.6% |
Total Liabilities | 2.5B | ↓ 2.67% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 5.4B | ↑ 0.1% |
Total Liabilities | 2.6B | ↑ 2.86% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 358.5M | ↑ 168.6% |
Investing Cash Flow | -258.5M | ↑ 7.67% |
Financing Cash Flow | -627.3M | ↓ 204.76% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 372.5M | ↑ 3.89% |
Investing Cash Flow | 262.8M | ↓ 201.68% |
Financing Cash Flow | -646.2M | ↑ 3.01% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 354.9M | ↓ 4.73% |
Investing Cash Flow | -136.5M | ↓ 151.91% |
Financing Cash Flow | -202.1M | ↓ 68.72% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 356.4M | ↑ 0.43% |
Investing Cash Flow | -336.2M | ↑ 146.39% |
Financing Cash Flow | 30.1M | ↓ 114.91% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 315.7M | ↓ 11.41% |
Investing Cash Flow | -216.2M | ↓ 35.68% |
Financing Cash Flow | -161.7M | ↓ 636.52% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 108.5M | ↑ 41.65% |
Investing Cash Flow | -57.0M | ↓ 37.28% |
Financing Cash Flow | -91.6M | ↓ 263.75% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 67.6M | ↓ 37.69% |
Investing Cash Flow | -31.2M | ↓ 45.32% |
Financing Cash Flow | -13.5M | ↓ 85.24% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 68.3M | ↑ 1.04% |
Investing Cash Flow | 113.2M | ↓ 463.21% |
Financing Cash Flow | -196.1M | ↑ 1350.34% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 70.3M | ↑ 2.99% |
Investing Cash Flow | -8.2M | ↓ 107.24% |
Financing Cash Flow | -68.5M | ↓ 65.08% |
Sell
Neutral
Buy
Sabra Health Care Reit Inc is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Sabra Health Care Reit Inc | -4.61% | -1.73% | 24.89% | -25.45% | -30.32% |
Healthpeak Properties, Inc. | 4.44% | 64.63% | 31.0% | -0.38% | -0.38% |
Ventas, Inc. | 2.38% | 3.02% | -5.37% | -22.03% | -28.4% |
Welltower Inc. | 3.29% | 13.2% | 23.41% | 23.86% | 26.11% |
Omega Healthcare Investors Inc. | 0.29% | -8.44% | 17.4% | -19.61% | -14.62% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Sabra Health Care Reit Inc | 228.33 | 228.33 | 3.15 | 0.58 | 0.0 | 0.02 | 0.09 | 12.12 |
Healthpeak Properties, Inc. | 33.27 | 33.27 | 3.19 | 0.4 | 0.05 | 0.02 | 0.06 | 11.61 |
Ventas, Inc. | 2223.5 | NA | 2.28 | -1.04 | 0.0 | 0.02 | 0.04 | 23.6 |
Welltower Inc. | 135.8 | 135.8 | 2.13 | 1.26 | 0.02 | 0.02 | 0.03 | 45.02 |
Omega Healthcare Investors Inc. | 30.68 | 30.68 | 1.13 | 1.37 | 0.07 | 0.03 | 0.09 | 14.57 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Sabra Health Care Reit Inc | Buy | $3.2B | -30.32% | 228.33 | 2.13% |
Healthpeak Properties, Inc. | Buy | $13.2B | -0.38% | 33.27 | 14.03% |
Ventas, Inc. | Buy | $17.6B | -28.4% | 2223.5 | -0.91% |
Welltower Inc. | Buy | $55.4B | 26.11% | 135.8 | 5.12% |
Omega Healthcare Investors Inc. | Hold | $7.8B | -14.62% | 30.68 | 25.5% |
BlackRock Inc
Vanguard Group Inc
Principal Financial Group Inc
State Street Corporation
JPMorgan Chase & Co
Geode Capital Management, LLC
In the quarter ending March,2024. Sabra Health Care Reit Inc has declared dividend of $0.3
Read Moresabra health care reit, inc. is a self-administered, self-managed realty company that owns and invests in real estate serving the healthcare industry. sabra, a maryland corporation, generates revenues by leasing properties to local, regional and national tenants and operators throughout the united states.
Organization | Sabra Health Care Reit Inc |
Employees | 48 |
CEO | Mr. Richard K. Matros |
Industry | Finance |
Patrick Industries Inc.
$13.94
+2.12%
Moonlake Immunotherapeutics
$13.94
+2.12%
H&e Equipment Services Inc
$13.94
+2.12%
N-able Inc.
$13.94
+2.12%
Cerevel Therapeutics Holdings Inc
$13.94
+2.12%
Spdr Bloomberg Barclays Intermediate Term Corp Bond Etf
$13.94
+2.12%
Brunswick Corporation
$13.94
+2.12%
Banco Macro S.a.
$13.94
+2.12%
Brazil Capped Etf Msci Ishares
$13.94
+2.12%